Bayer Plunges to Two-Decade Low on Weaker Profit Guidance
- Sales outlook lowered at agricultural, consumer health units
- Bayer sees pharma division sales at high end of guidance
This article is for subscribers only.
Bayer AG shares plunged to the lowest in two decades after the German conglomerate cut profit guidance for this year and said earnings will probably fall in 2025.
The stock tumbled as much as 14% in German trading, the biggest intraday drop since last November, bringing the decline this year to 36%.